PortfoliosLab logoPortfoliosLab logo
ALTO vs. BIOX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALTO vs. BIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alto Ingredients, Inc. (ALTO) and Bioceres Crop Solutions Corp. (BIOX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALTO achieves a 92.01% return, which is significantly higher than BIOX's -64.93% return.


ALTO

1D
-2.47%
1M
1.10%
YTD
92.01%
6M
97.50%
1Y
482.53%
3Y*
37.87%
5Y*
-1.68%
10Y*
-1.54%

BIOX

1D
-6.34%
1M
2.87%
YTD
-64.93%
6M
-71.11%
1Y
-90.81%
3Y*
-66.93%
5Y*
-49.68%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALTO vs. BIOX - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ALTO
Alto Ingredients, Inc.
92.01%84.62%-41.35%-7.64%-40.12%-11.42%735.38%-24.51%-73.91%
BIOX
Bioceres Crop Solutions Corp.
-64.93%-78.45%-55.72%14.13%-14.92%128.06%22.80%-49.86%4.90%

Correlation

The correlation between ALTO and BIOX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Mar 23, 2018

0.14

Fundamentals

Market Cap

ALTO:

$423.81M

BIOX:

$29.22M

EPS

ALTO:

$0.38

BIOX:

-$3.84

PS Ratio

ALTO:

0.46

BIOX:

0.11

Total Revenue (TTM)

ALTO:

$916.07M

BIOX:

$263.71M

Gross Profit (TTM)

ALTO:

$45.94M

BIOX:

$97.66M

EBITDA (TTM)

ALTO:

$20.37M

BIOX:

-$1.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALTO vs. BIOX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALTO
ALTO Risk / Return Rank: 9898
Overall Rank
ALTO Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
ALTO Sortino Ratio Rank: 9696
Sortino Ratio Rank
ALTO Omega Ratio Rank: 9696
Omega Ratio Rank
ALTO Calmar Ratio Rank: 9999
Calmar Ratio Rank
ALTO Martin Ratio Rank: 9999
Martin Ratio Rank

BIOX
BIOX Risk / Return Rank: 55
Overall Rank
BIOX Sharpe Ratio Rank: 77
Sharpe Ratio Rank
BIOX Sortino Ratio Rank: 11
Sortino Ratio Rank
BIOX Omega Ratio Rank: 22
Omega Ratio Rank
BIOX Calmar Ratio Rank: 22
Calmar Ratio Rank
BIOX Martin Ratio Rank: 1111
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALTO vs. BIOX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alto Ingredients, Inc. (ALTO) and Bioceres Crop Solutions Corp. (BIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALTOBIOXDifference

Sharpe ratio

Return per unit of total volatility

5.07

-0.89

+5.96

Sortino ratio

Return per unit of downside risk

4.48

-2.39

+6.87

Omega ratio

Gain probability vs. loss probability

1.64

0.73

+0.90

Calmar ratio

Return relative to maximum drawdown

17.00

-0.98

+17.98

Martin ratio

Return relative to average drawdown

39.94

-1.30

+41.24

ALTO vs. BIOX - Sharpe Ratio Comparison

The current ALTO Sharpe Ratio is 5.07, which is higher than the BIOX Sharpe Ratio of -0.89. The chart below compares the historical Sharpe Ratios of ALTO and BIOX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ALTOBIOXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

5.07

-0.89

+5.96

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.02

-0.78

+0.76

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.21

-0.48

+0.27

Drawdowns

ALTO vs. BIOX - Drawdown Comparison

The maximum ALTO drawdown since its inception was -99.99%, roughly equal to the maximum BIOX drawdown of -97.68%. Use the drawdown chart below to compare losses from any high point for ALTO and BIOX.


Loading charts...

Drawdown Indicators


ALTOBIOXDifference

Max Drawdown

Largest peak-to-trough decline

-99.99%

-97.68%

-2.31%

Max Drawdown (1Y)

Largest decline over 1 year

-28.62%

-92.66%

+64.04%

Max Drawdown (3Y)

Largest decline over 3 years

-84.11%

-97.33%

+13.22%

Max Drawdown (5Y)

Largest decline over 5 years

-89.12%

-97.68%

+8.56%

Max Drawdown (10Y)

Largest decline over 10 years

-97.77%

Current Drawdown

Current decline from peak

-99.88%

-97.13%

-2.75%

Average Drawdown

Average peak-to-trough decline

-92.32%

-36.08%

-56.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.16%

69.65%

-57.49%

Volatility

ALTO vs. BIOX - Volatility Comparison

The current volatility for Alto Ingredients, Inc. (ALTO) is 30.02%, while Bioceres Crop Solutions Corp. (BIOX) has a volatility of 32.05%. This indicates that ALTO experiences smaller price fluctuations and is considered to be less risky than BIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALTOBIOXDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.02%

32.05%

-2.03%

Volatility (6M)

Calculated over the trailing 6-month period

68.58%

83.83%

-15.25%

Volatility (1Y)

Calculated over the trailing 1-year period

95.99%

102.46%

-6.47%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.46%

64.21%

+15.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

90.65%

64.99%

+25.66%

Dividends

ALTO vs. BIOX - Dividend Comparison

Neither ALTO nor BIOX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ALTO vs. BIOX - Financials Comparison

This section allows you to compare key financial metrics between Alto Ingredients, Inc. and Bioceres Crop Solutions Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M400.00M20222023202420252026
224.68M
38.20M
(ALTO) Total Revenue
(BIOX) Total Revenue
Values in USD except per share items

ALTO vs. BIOX - Profitability Comparison

The chart below illustrates the profitability comparison between Alto Ingredients, Inc. and Bioceres Crop Solutions Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%20222023202420252026
4.1%
30.1%
Portfolio components
ALTO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a gross profit of 9.22M and revenue of 224.68M. Therefore, the gross margin over that period was 4.1%.

BIOX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported a gross profit of 11.50M and revenue of 38.20M. Therefore, the gross margin over that period was 30.1%.

ALTO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported an operating income of 2.52M and revenue of 224.68M, resulting in an operating margin of 1.1%.

BIOX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported an operating income of -6.50M and revenue of 38.20M, resulting in an operating margin of -17.0%.

ALTO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alto Ingredients, Inc. reported a net income of 3.96M and revenue of 224.68M, resulting in a net margin of 1.8%.

BIOX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioceres Crop Solutions Corp. reported a net income of -8.90M and revenue of 38.20M, resulting in a net margin of -23.3%.


Frequently Asked Questions


ALTO and BIOX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BIOX has higher volatility (32.05%) compared to ALTO (30.02%). In terms of maximum drawdown, ALTO dropped -99.99% vs BIOX's -97.68%.

ALTO currently has the higher Sharpe Ratio (5.07 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALTO and BIOX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer